Skip to main content
Log in

DNA methylation haplotypes as cancer markers

  • Correspondence
  • Published:

From Nature Genetics

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Distribution of the estimated whole blood cfDNA proportions in normal, colorectal cancer and lung cancer plasma.

References

  1. Guo, S. et al. Nat. Genet. 49, 635–642 (2017).

    Article  CAS  Google Scholar 

  2. Sun, K. et al. Proc. Natl. Acad. Sci. USA 112, E5503–E5512 (2015).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John M. Greally.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seoighe, C., Tosh, N.J. & Greally, J.M. DNA methylation haplotypes as cancer markers. Nat Genet 50, 1062–1063 (2018). https://doi.org/10.1038/s41588-018-0185-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41588-018-0185-x

  • Springer Nature America, Inc.

This article is cited by

Navigation